Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection (2020)
Attributed to:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.01.362319
Publication URI: http://dx.doi.org/10.1101/2020.11.01.362319
Type: Preprint